info@news-matic.com

details

FDA Finalizes 3 Guidance Documents to Broaden Cancer Clinical Trial Eligibility Criteria

The FDA issued final guidances on performance status, washout periods, and laboratory values aimed at expanding oncology trial participation.

ADVERTISEMENT

Cookie Consent + Tracking